We are live on ! Find out more
BLFS icon

BioLife Solutions

54 hedge funds and large institutions have $133M invested in BioLife Solutions in 2018 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 15 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

157% more capital invested

Capital invested by funds: $51.9M → $133M (+$81.4M)

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

71% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 7

47% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 15

16.06% more ownership

Funds ownership: 30.09%46.15% (+16%)

10% more funds holding

Funds holding: 4954 (+5)

Holders
54
Holders Change
+5
Holders Change %
+10.2%
% of All Funds
1.23%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
12
Increased
22
Reduced
15
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$730K +$503K +25,422 +156%
New York State Common Retirement Fund
27
New York State Common Retirement Fund
New York
$700K
Invesco
28
Invesco
Georgia
$587K +$131K +6,609 +25%
OAM
29
Oxford Asset Management
United Kingdom
$521K +$590K +29,836 New
PA
30
Perceptive Advisors
New York
$514K +$581K +29,376 New
Deutsche Bank
31
Deutsche Bank
Germany
$473K -$2.14M -107,985 -80%
Jane Street
32
Jane Street
New York
$382K +$132K +6,660 +44%
Bank of Montreal
33
Bank of Montreal
Ontario, Canada
$338K +$182K +9,222 +92%
MIM
34
Monashee Investment Management
Massachusetts
$337K
Janney Montgomery Scott
35
Janney Montgomery Scott
Pennsylvania
$335K -$110K -5,550 -23%
Two Sigma Advisers
36
Two Sigma Advisers
New York
$294K +$91K +4,600 +38%
T. Rowe Price Associates
37
T. Rowe Price Associates
Maryland
$261K -$263K -13,300 -47%
SKK
38
Shepherd Kaplan Krochuk
Massachusetts
$245K -$39.6K -2,000 -13%
GCP
39
GSA Capital Partners
United Kingdom
$200K +$226K +11,400 New
PNC Financial Services Group
40
PNC Financial Services Group
Pennsylvania
$105K -$79.1K -4,000 -40%
First Manhattan
41
First Manhattan
New York
$87K -$138K -7,000 -58%
AA
42
Ancora Advisors
Ohio
$44K +$49.5K +2,500 New
UBS Group
43
UBS Group
Switzerland
$27K -$25.5K -1,291 -46%
Macquarie Group
44
Macquarie Group
Australia
$10K -$140K -7,100 -92%
LTFS
45
Ladenburg Thalmann Financial Services
Florida
$10K +$11.4K +577 New
QT
46
Quantbot Technologies
New York
$10K +$12.3K +621 New
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$9K +$79 +4 +0.8%
Barclays
48
Barclays
United Kingdom
$7K +$7.91K +400 New
Bank of America
49
Bank of America
North Carolina
$6K +$2.69K +136 +59%
PCM
50
Prelude Capital Management
New York
$3K +$3.82K +193 New

BLFS Hedge Fund Activity: Q3 2018 in Review

54 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q3 2018, worth a combined $133M — up 157% from $51.9M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new BLFS positions and 7 closed out — a net gain of 5 holders — while 22 added to existing stakes and 15 trimmed.

The largest buyer was Casdin Capital, adding an estimated $28.3M. The largest seller was Deutsche Bank, cutting an estimated $2.14M.

  • 54 institutional investors held BioLife Solutions (BLFS) as of Q3 2018, up from 49 in Q2 2018.
  • Funds reported $133M of BioLife Solutions stock for Q3 2018, up 157% quarter-over-quarter.
  • 12 funds opened new BioLife Solutions positions in Q3 2018 and 7 closed out, a net change of +5 holders.
  • The largest BioLife Solutions buyer in Q3 2018 was Casdin Capital, an estimated $28.3M added.
  • The largest BioLife Solutions seller in Q3 2018 was Deutsche Bank, an estimated $2.14M sold.

Based on aggregated 13F filings for Q3 2018.